Hritvik Jain, Andrew M. Goldsweig/LinkedIn
Oct 29, 2025, 07:09
Hritvik Jain and Andrew Goldsweig Shared Risk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
Hritvik Jain, Founding President of EnigmaMed Research Initiative, shared a post on X:
“In our latest publication in The Canadian Journal of Cardiology (CJC), we report risk of MACCE, AMI, and readmission in IBD patients undergoing PCI! Thanks to Andrew M. Goldsweig guidance and mentorship”
Title: Outcomes of Percutaneous Coronary Intervention in Patients with Inflammatory Bowel Disease: A Propensity-Score Matched Analysis
Authors: Hritvik Jain, Nandan Patel, Jyoti Jain, Kriti Soni, Siddharth P. Agrawal, Bala Pushparaji, Richard Malone, Mohammed Absar Ullah, Andrew M. Goldsweig
Read full article here.
Stay informed with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids